201 BROOKLINE AVENUE, BOSTON, MA
Market cap: $994.0M (7/24/2025)
Price: $11.13
News, Articles of Incorporation, Bylaws
Changes in Board, Management or Compensation
To acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Shareholder votes
Announces Pipeline Progress and Reports First Quarter 2025 Financial Results
Annual Report to Security Holders
Other Events
Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results
Q1
Q3
Q2
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
S-8 POS